Evidence map›Paper›PMID 21408057›Full record

ArticlePloS one2011

Cerebral changes occurring in arginase and dimethylarginine dimethylaminohydrolase (DDAH) in a rat model of sleeping sickness.

Donia Amrouni, Anne Meiller, Sabine Gautier-Sauvigné, Monique Piraud, Bernard Bouteille, Philippe Vincendeau, Alain Buguet, Raymond Cespuglio

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. The Emerging Role of the DDAH Proteins in Psychiatric Disorders.Biological psychiatry global open science · 2025
    Review
  2. From pole to pole, life-long research of sleep in extreme environments.Sleep advances : a journal of the Sleep Research Society · 2024
    Article
  3. Coinfection withJournal of tropical medicine · 2023
    Article
  4. Article
  5. DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury.International journal of molecular sciences · 2014
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Donia AmrouniUniversité Claude Bernard Lyon 1, Faculté de Médecine, EA 4170 and Plateau NeuroChem, Lyon, France.
Anne Meiller
Sabine Gautier-Sauvigné
Monique Piraud
Bernard Bouteille
Philippe Vincendeau
Alain Buguet
Raymond Cespuglio
Université Claude Bernard Lyon 1 · FRCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRHospices Civils de Lyon · FRInstitut d’Epidémiologie Neurologique et de Neurologie Tropicale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInvolvement of nitric oxide (NO) in the pathophysiology of human African trypanosomiasis (HAT) was analyzed in a HAT animal model (rat infected with Trypanosoma brucei brucei). With this model, it was previously reported that trypanosomes were capable of limiting trypanocidal properties carried by NO by decreasing its blood concentration. It was also observed that brain NO concentration, contrary to blood, increases throughout the infection process. The present approach analyses the brain impairments occurring in the regulations exerted by arginase and N(G), N(G)-dimethylarginine dimethylaminohydrolase (DDAH) on NO Synthases (NOS). In this respect: (i) cerebral enzymatic activities, mRNA and protein expression of arginase and DDAH were determined; (ii) immunohistochemical distribution and morphometric parameters of cells expressing DDAH-1 and DDAH-2 isoforms were examined within the diencephalon; (iii) amino acid profiles relating to NOS/arginase/DDAH pathways were established. METHODOLOGY/PRINCIPAL

findingsArginase and DDAH activities together with mRNA (RT-PCR) and protein (western-blot) expressions were determined in diencephalic brain structures of healthy or infected rats at various days post-infection (D5, D10, D16, D22). While arginase activity remained constant, that of DDAH increased at D10 (+65%) and D16 (+51%) in agreement with western-blot and amino acids data (liquid chromatography tandem-mass spectrometry). Only DDAH-2 isoform appeared to be up-regulated at the transcriptional level throughout the infection process. Immunohistochemical staining further revealed that DDAH-1 and DDAH-2 are contained within interneurons and neurons, respectively. CONCLUSION/SIGNIFICANCE: In the brain of infected animals, the lack of change observed in arginase activity indicates that polyamine production is not enhanced. Increases in DDAH-2 isoform may contribute to the overproduction of NO. These changes are at variance with those reported in the periphery. As a whole, the above processes may ensure additive protection against trypanosome entry into the brain, i.e., maintenance of NO trypanocidal pressure and limitation of polyamine production, necessary for trypanosome growth.

Indexed as

AmidohydrolasesAmino AcidsAnimalsArginaseBiosynthetic PathwaysBrainDisease Models, AnimalDisease ProgressionGene Expression Regulation, EnzymologicHumansIsoenzymesMaleMass SpectrometryModels, BiologicalRatsRats, WistarAmidohydrolasesAmino AcidsArginasedimethylargininaseIsoenzymesRNA, Messenger

Identifiers

PMID21408057
PMCPMC3052300
OpenAlexW1978320920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.